Avadel Pharmaceuticals (AVDL) PT Lowered to $10 at Ladenburg Thalmann
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Nasdaq eyes lower open after midterms-fueled surge as chip, data center stocks fall
- Massive market rotation raises question: Is the sell-AI trade here to stay?
- Goldman sees major AI and data center policy implications from ‘blue tsunami’
- Apple seeks to raise up to $7 billion in seven-tranche bond offering
- Nvidia chips stockpile in Hong Kong awaits China import approval - report
Tweet
Share
E-mailGet Alerts AVDL Hot Sheet
Price: $21.64 --0%
Rating Summary:
5 Buy, 10 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 20 | Down: 37 | New: 6
Rating Summary:
5 Buy, 10 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 20 | Down: 37 | New: 6
Join SI Premium – FREE
Ladenburg Thalmann analyst Matthew Kaplan lowered the price target on Avadel Pharmaceuticals (NASDAQ: AVDL) to $10.00 (from $17.50) while maintaining a Buy rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AppLovin Corp (APP) PT Raised to $355 at Piper Sandler
- Climb Bio (CLYM) PT Raised to $27 at Wedbush, 'remains on our Wedbush Best Ideas List'
- McDonald's (MCD) PT Raised to $307 at KeyBanc
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
Ladenburg Thalmann Financial ServicesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
